Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior

Further Publications NeurologyFurther Publications Psychiatry

NMDA receptor antagonists and pain relief: A meta-analysis of experimental trials

Neurology.

Thompson T, Whiter F, Gallop K, Veronese N, Solmi M, Newton P, Stubbs B

doi: 10.1212/WNL.

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

Neurology.

Scheibe F, Prüss H, Mengel AM, Kohler S, Nümann A, Köhnlein M, Ruprecht K, Alexander T, Hiepe F, Meisel A

doi: 10.1212/

Migraine and Headache

Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions

Cephalalgia.

Ashina M, Kudrow D, Reuter U, Dolezil D, Silberstein S, Tepper SJ, Xue F, Picard H, Zhang F, Wang A, Zhou Y, Hong F, Klatt J, Mikol DD

doi: 10.1177/0333102419888222.

Dementia

Therapies for Prevention and Treatment of Alzheimer's Disease

Biomed Res Int.

Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G

doi: 10.1155/2016/2589276.

Migraine and Headache

Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial

Cephalalgia

Wienholtz NKF, Christensen CE, Zhang DG, Coskun H, Ghanizada H, Al-Karagholi MA, Hannibal J, Egeberg A, Thyssen JP, Ashina M

doi: 10.1177/0333102420975395

Psychosis and Schizophrenia

Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia

JAMA Psychiatry.

Kugathasan P, Horsdal HT, Aagaard J, Jensen SE, Laursen TM, Nielsen RE

doi: 10.1001/jamapsychiatry.

Anxiety and Depression

Randomized, Placebo-Controlled Trial of the Angiotensin Receptor Antagonist Losartan for Posttraumatic Stress Disorder

Biol Psychiatry

Stein MB, Jain S, Simon NM, West JC, Marvar PJ, Bui E, He F, Benedek DM, Cassano P, Griffith JL, Howlett J, Malgaroli M, Melaragno A, Seligowski AV, Shu IW, Song S, Szuhany K, Taylor CT, Ressler KJ, LOSe-PTSD Investigators.

doi: 10.1016/j.biopsych.2021.05.012

Psychosis and Schizophrenia

The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review

J Psychiatr Res.

Girgis RR, Zoghbi AW, Javitt DC, Lieberman JA

doi: 10.1016/j.jpsychires.

Aging and Cognitive FunctionsAnxiety and DepressionBipolar DisorderPsychosis and Schizophrenia

Effectiveness of preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in prevention of depressive relapse or recurrence (DRD study): a three-group, multicentre, randomised controlled trial

Lancet Psychiatry.

Bockting CLH, Klein NS, Elgersma HJ, van Rijsbergen GD, Slofstra C, Ormel J, Buskens E, Dekker J, de Jong PJ, Nolen WA, Schene AH, Hollon SD, Burger H

doi: 10.1016/

Related content